On August 12 of this year the US senate unanimously passed the Race to Accelerate Cures and Equity for Children Act (RACE) expanding on the already enacted Pediatric Research Equity Act (P
GSK has pulled off a major coup, replacing outgoing chief science officer Patrick Vallance with Calico and former Roche/Genentech whizz, Dr Hal Barron with a bumper pay package that could b
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
